Maraolo, A.E.; Giaccone, A.; Gentile, I.; Saracino, A.; Bavaro, D.F.
Daptomycin versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection with or without Endocarditis: A Systematic Review and Meta-Analysis. Antibiotics 2021, 10, 1014.
https://doi.org/10.3390/antibiotics10081014
AMA Style
Maraolo AE, Giaccone A, Gentile I, Saracino A, Bavaro DF.
Daptomycin versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection with or without Endocarditis: A Systematic Review and Meta-Analysis. Antibiotics. 2021; 10(8):1014.
https://doi.org/10.3390/antibiotics10081014
Chicago/Turabian Style
Maraolo, Alberto Enrico, Agnese Giaccone, Ivan Gentile, Annalisa Saracino, and Davide Fiore Bavaro.
2021. "Daptomycin versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection with or without Endocarditis: A Systematic Review and Meta-Analysis" Antibiotics 10, no. 8: 1014.
https://doi.org/10.3390/antibiotics10081014
APA Style
Maraolo, A. E., Giaccone, A., Gentile, I., Saracino, A., & Bavaro, D. F.
(2021). Daptomycin versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection with or without Endocarditis: A Systematic Review and Meta-Analysis. Antibiotics, 10(8), 1014.
https://doi.org/10.3390/antibiotics10081014